DIVA Laboratories Ltd (4153) — Financial Flexibility Index
DIVA Laboratories Ltd (4153) has a Financial Flexibility Index of 0.02x as of December 2025. Free cash flow of NT$5.81 Million (operating CF NT$5.57 Million minus capex NT$241.00K) represents 0% of total liabilities (NT$324.52 Million). Also explore DIVA Laboratories Ltd (4153) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
DIVA Laboratories Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for DIVA Laboratories Ltd across 9 annual periods. Check DIVA Laboratories Ltd (4153) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for DIVA Laboratories Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for DIVA Laboratories Ltd. For the full company profile including market capitalisation, see DIVA Laboratories Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.07x | NT$21.77 Million | NT$20.77 Million | NT$324.52 Million | ▼ -86.6% |
| 2024 | 0.50x | NT$125.27 Million | NT$123.14 Million | NT$249.94 Million | ▼ -59.4% |
| 2023 | 1.24x | NT$260.60 Million | NT$252.91 Million | NT$210.93 Million | ▲ +244.1% |
| 2022 | 0.36x | NT$84.60 Million | NT$73.19 Million | NT$235.62 Million | ▲ +4702.4% |
| 2021 | 0.01x | NT$1.46 Million | NT$-11.39 Million | NT$195.27 Million | ▼ -81.8% |
| 2020 | 0.04x | NT$5.12 Million | NT$-16.64 Million | NT$124.34 Million | ▼ -89.4% |
| 2019 | 0.39x | NT$65.46 Million | NT$52.66 Million | NT$168.09 Million | ▼ -49.8% |
| 2018 | 0.78x | NT$107.73 Million | NT$86.02 Million | NT$138.87 Million | ▲ +261.0% |
| 2017 | 0.21x | NT$54.76 Million | NT$41.45 Million | NT$254.84 Million | — |